MoleculeGo im Vergleich zu BioViewer Nutzung und Statistiken

MoleculeGo is a location based app that gamifies the process of learning about molecular biology. In this game, the player collects amino acids, ATP, and DNA sequences, the molecular building blocks used to synthesize proteins. By capturing DNA sequences, the player discovers genes that encode for proteins. These genes provide the user with the necessary "recipe" to synthesize proteins in their own lab, using amino acids and ATP. These proteins can then be combined to construct even larger protein complexes. As the player progresses in the game, new molecules become available and information will become available about each molecule's basic function and how its structure is associated with its molecular role. Players can visit hotspots (schools, parks, hospitals, universities, etc.) to accelerate the discovery of new molecules. While molecules are discovered, players can learn how they are involved in disease, biomedical applications, research, and their function in the cell.
  • Apple App Store
  • Kostenlos
  • Bildung

Rang speichern

- -

A .pdb protein visualizer for iOS, iPadOS and macOS. View the 3D representation of any molecular structure from a .pdb file, using our custom Metal-based rendering engine based to allow for a smooth experience even in the biggest proteins.  - Full drag and drop support for .pdb and .xyz files. - Photo Mode with publication-quality exports. - Support for multi-model PDBs. - Support for high refresh rate ProMotion displays.
  • Apple App Store
  • Kostenlos
  • Bildung

Rang speichern

- -

MoleculeGovs. BioViewer Ranking-Vergleich

Vergleichen Sie MoleculeGo den Ranking-Trend der letzten 28 Tage mit BioViewer

Rang

Keine Daten verfügbar

MoleculeGo im Vergleich zu BioViewer Ranking im Ländervergleich

Vergleichen Sie MoleculeGo den Ranking-Trend der letzten 28 Tage mit BioViewer

Keine Daten zum Anzeigen

Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an

Los geht's
MoleculeGo VS.
BioViewer

Dezember 17, 2024